Cancer

November 7, 2024

A high-resolution macrostudy opens the door to tightening the noose in the fight against cancer

Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, reflects on cancer following the publication of the series of articles by the Nature group, which represent an unprecedented analysis of this disease, turning everything known upside down.
October 15, 2024

Tarazona turns pink at the 'Centinela Running' to raise funds for a project of the IIS Aragón

The eighth edition of this march will be held on 19 and 20 October and all proceeds will be donated to a research project on metastatic breast cancer. This initiative will include a 24-hour non-stop charity challenge and a march commemorating World Breast Cancer Day.
September 23, 2024

773 cyclists collaborate for children with cancer in the BTT Aspanoa 2024

Rain was the star of the twelfth edition of the BTT Aspanoa, held last Saturday in Almudévar, a municipality in Huesca where the Association has a House where it organizes camps, get-togethers and respites for children with cancer and their families.
September 18, 2024

Luis Alberto Anel Bernal: “A research career, and especially in this field, is a long-distance race that not everyone is suited to”

In this interview, the IIS Aragón researcher talks about his work leading the Apoptosis, Immunity and Cancer Group (GIIS090) and his research interests.
Augusts 29, 2024

New algorithm facilitates personalized treatments for genetic disorders and cancer

The RTD detective computational model, developed by CRG researchers and published in Nature Genetics, predicts the efficacy of drugs for pathologies caused by genetic mutations. Based on data from more than 5000 patients, the system promises to accelerate the development of targeted therapies and optimize clinical trials.
Augusts 14, 2024

A large genomic map of colorectal cancer seeks to improve its treatment

The development of this atlas has been possible thanks to the complete genome sequencing of 2023 colon tumors. The data generated from the analysis is accessible to the scientific community.